
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
[ Fri, Nov 19th 2021 ]: WOPRAI
Evan Seigerman Initiated (BIIB) at Buy and Held Target at $315 on, Nov 19th, 2021


🞛 This publication is a summary or evaluation of another publication
Evan Seigerman of BMO Capital, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $315 on, Nov 19th, 2021.
Evan has made no other calls on BIIB in the last 4 months.
There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 3 agree with Evan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $270 on, Tuesday, October 26th, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021
These are the ratings of the 8 analyists that currently disagree with Evan
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $386 on, Thursday, October 21st, 2021
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $390 on, Thursday, October 21st, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $440 on, Thursday, October 21st, 2021
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
- Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021